Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity

Gynecologic Cancer

Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 - A multinational population-based cohort study

Eur J Cancer

Hardie AN, Wenzel HHB, Schnack TH, Van der Aa MA, Jensen PT, Bekkers RLM, Falconer H, Dutch, dANish and sweDish gynaEcoLogIcal ONcology (DANDELION) research group

doi: 10.1016/j.ejca.2025.115664

Central Nervous System Tumors

RANO seizure working group-Tumor Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice

Neuro Oncol

Avila EK, Reiner AS, Armstrong TS, Aaroe AE, Cunningham EM, Brown JG, Bruno F, Diarte J, Haggiagi A, Harrison RA, Joanta-Gomez A, Koekkoek JAF, Lee EQ, Le Rhun E, Miller H, Panageas KS, Peguero EN, Ruda R, Soffietti R, Templer JW, Tobochnik S, Vera E, Vogelbaum MA, Weller M, van den Bent M

doi: 10.1093/neuonc/noaf165

Genitourinary Cancer

SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis

Eur Urol

Herrmann K, Walz J, MacLennan S, Briganti A, Cornford P, Czernin J, Eiber M, Fanti S, Fendler WP, Fizazi K, Gafita A, Gillessen S, Goffin K, Hadaschik B, Hofman MS, Hope TA, Maurer T, Morgans AK, Morris MJ, Murphy DG, Oprea-Lager DE, Ost P, ÓSullivan JM, Rouvière O, Sandhu S, Sartor O, Sathekge MM, Tempany C, Witjes W, Emmett L, Bjartell AS

doi: 10.1016/j.eururo.2025.08.005

Multiple Myeloma (MM)

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma

J Clin Oncol

Avet-Loiseau H, Davies FE, Samur MK, Corre J, D'Agostino M, Kaiser MF, Raab MS, Weinhold N, Gutierrez NC, Paiva SB, Neri P, Weisel K, Maura F, Walker BA, Bustoros M, Stewart AK, Usmani SZ, Hillengass J, Chng WJ, Keats JJ, Martinez-Lopez J, Sperling AS, Touzeau C, Zhan F, Raje NS, Cavo M, Bolli N, Ghobrial IM, Dhodapkar MV, Jagannath S, Spencer A, Parekh S, Bahlis NJ, Lonial S, Sonneveld P, Bergsagel L, Orlowski RZ, Morgan G, Mateos MV, Rajkumar SV, San Miguel JF, Anderson KC, Moreau P, Kumar S, Prósper F, Munshi NC

doi: 10.1200/JCO-24-01893

Head and Neck Cancer

Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)

J Natl Cancer Inst

Williamson A, Brady G, Harris N, Haris PA, Bisase B, Chiu K, Douglas C, Fleming J, Hamilton D, Haridass A, Hughes C, Iqbal MS, Kerawala C, King E, Liu Z, McCaul J, Montgomery J, Nankivell P, Nixon I, Noble D, Nugent M, Paterson C, Pracy P, Riva F, Roe J, Schache A, Selbong U, Schilling C, Simo R, Winter S, O'Leary B, Paleri V

doi: 10.1093/jnci/djaf128

Lung, Respiratory and Thoracic Cancer

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

Cancer

Florez N, Patel S, Wakelee HA, Rotow J, Shum E, Sands J, Salgia R, Hirsch FR, Peters S, Sabari J, Husain H, Bazhenova L, Massarelli E, Backhus LM, Lee P, Herbst RS, Bestvina C, Higgins K, Desai A, Dietrich M, Keshava HB, Halmos B, Gandara DR, Riess JW, Velázquez AI, Sibley A, Shields M, Sen T, Kim ES

doi: 10.1002/cncr.70060

CHICAGO 2025

Genitourinary Cancer

PRECISION: Real-world outcomes following guideline-recommended therapies after ¹⁷⁷Lu-PSMA-617 in mCRPC

Further Publications

Cancer and Overgrowth Manifestations of PTEN Hamartoma Tumour Syndrome: Management Recommendations from the International PHTS Consensus Guidelines Working Group

Clin Cancer Res

Dhawan A, Baitamouni S, Liu D, Yehia L, Anthony K, McCarther A, Tischkowitz M, MacFarland SP, Ngeow J, Hoogerbrugge N, Eng C

doi: 10.1158/1078-0432.CCR-24-3819

Breast Cancer

Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial